• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 50MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 50MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74120150
Device Problems Loss of Osseointegration (2408); Biocompatibility (2886); Migration (4003)
Patient Problems Pocket Erosion (2013); Osteolysis (2377); Metal Related Pathology (4530); Implant Pain (4561)
Event Date 04/15/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
Us legal.It was reported that the plaintiff underwent a revision surgery of the right hip on (b)(6) 2019 due to pain, elevated metal ion levels and suspected metal debris.The outcome of the patient is unknown.The primary right bhr surgery was performed on (b)(6) 2009.
 
Event Description
It was reported that the plaintiff underwent a revision surgery of the right hip on (b)(6) 2019 due to pain, elevated metal ion levels and suspected metal debris.During the revision moderate to severe periprosthetic femoral neck osteolysis with erosion of the femoral neck under the resurfacing femoral component was noticed, as well as a moderate sized osteolytic defect posterior to the acetabulum.The metallic cup and femoral head were explanted and replaced with a tha system from a competitor.The patient tolerated the procedure well and was taken to the recovery room in good condition.The primary right bhr surgery was performed on (b)(6) 2009.
 
Manufacturer Narrative
Internal reference number: (b)(4).
 
Manufacturer Narrative
H3, h6: it was reported that a right hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information has been requested for this complaint but has not become available.Since part/lot details were not received for investigation no thorough manufacturing record review can be performed.If the products or additional information become available in the future, the tasks will be reopened and performed.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.Although it was reported the patient had elevated metal ions, neither the levels nor the lab reports were provided for review.Without the supporting lab/pathology results, imaging, and/or the analysis of the explanted components, the root cause of the reported pain and elevated metal ion levels cannot be confirmed.However, the patient¿s comorbidities and ¿grossly retroverted and somewhat vertical¿ acetabulum cannot be ruled out as a contributory factor of the reported clinical reactions.Without the return of the devices used in treatment or additional information we cannot advance the investigation or confirm this complaint; our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, loosening of components.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Manufacturer Narrative
H10: additional information in h7 and h9.H9: the concomitant product was also recalled.Fda recall - z-2745-2015 for 74121142 / resurfacing femoral head 42mm / lot# 086332.H3, h6.It was reported that a right hip revision surgery was performed due to pain, elevated metal ion levels (chromium = 3.3 g/ml) and suspected metal debris.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the devices concerned was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the cup and the head.This will continue to be monitored via routine trending, however it should be noted that these devices are no longer sold.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.With the information provided, the clinical root cause of the reported pain and elevated metal ion levels cannot be confirmed.However, the patient¿s comorbidities and ¿grossly retroverted and somewhat vertical¿ acetabulum cannot be ruled out as a contributory factor of the reported clinical reactions.It is noted, 72 days post revision, the patient was ¿doing great with the right revision total hip.¿ based on the information provided, further investigation of the reported complaint cannot be carried out and remains inconclusive.A definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Event Description
It was reported that, after undergoing right hip bhr resurfacing surgery on (b)(6) 2009 due to advanced post-traumatic hip degenerative joint disease, the patient experienced pain, elevated metal ion levels (chromium = 3.3 g/ml) and suspected metal debris.These conditions were treated by performing a revision surgery on (b)(6) 2019, in which moderate to severe periprosthetic femoral neck osteolysis with erosion of the femoral neck was found under the resurfacing femoral component.In addition, moderate sized osteolytic defect was noticed posterior to the acetabulum.Both the metallic cup and femoral head were explanted and replaced with a competitor¿s tha system (zimmer-biomet).The patient tolerated the procedure well and was taken to the recovery room in good condition.
 
Manufacturer Narrative
H10 ¿ additional information b5- describe event or problem b6- relevant tests b7- other relevant history d4 - catalog number, lot number, expiration date, unique identifier (udi) # g4 - pma/510(k)number h4 - device manufacture date h11 ¿ corrected data b2- outcomes attributed to adverse event d1- brand name e1- initial reporter name and address g2- report source h6- evaluation codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACETLR CUP HAP 50MM W/ IMPTR
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key13242370
MDR Text Key283749647
Report Number3005975929-2022-00011
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010502568
UDI-Public3596010502568
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional,User Facility
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 07/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/30/2012
Device Catalogue Number74120150
Device Lot Number70564
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/31/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-2746-2015
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention; Hospitalization;
Patient Age60 YR
Patient SexMale
-
-